Aridis Pharmaceuticals Inc.

Aridis Pharmaceuticals Inc. financial statements

Aridis Pharmaceuticals Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

FY2022

RevenueUSD 19.25MEODHD
Net income−USD 30.75MEODHD
Cash and equivalentsUSD 4.88MEODHD
Total debtUSD 6.13MEODHD

Aridis Pharmaceuticals Inc. financials on 6ix · Aridis Pharmaceuticals Inc. on 6ix